achromatic patches has been reported frequently, our patient has the distinctive feature of concurrent presence of multiple large hyperpigmented patches all over the body. It may be attributed to the fact that Waardenburg syndrome occurs due to aberrant development and/or migration of melanocyte precursors to epidermis. We were unable to find any previous reports of a similar presentation in a case of Waardenburg syndrome type 1.
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Leukemia cutis preceding bone marrow relapse in acute monocytic leukemia Sir, Leukemia cutis is a non-specific term used to describe an extra-medullary manifestation of any type of leukemia characterized by skin infiltration (epidermis, dermis or subcutaneous tissues) with neoplastic leukemic cells resulting in clinically identifiable skin lesions. [1] [2] [3] A 50-year-old woman presented to the hematology department with a 2-week history of generalized nodular skin lesions along with mild bone pain and fever. The patient had a history of acute monocytic leukemia which was diagnosed 6 months prior to the present admission. She experienced a complete remission which lasted for 5-6 months following an induction course of chemotherapy with cytosine arabinocide and daunorubicin (7 + 3) and three additional consolidation courses of the same protocol (5 + 2).
On examination, we found that the skin lesions were of different shapes and sizes ranging from small to large nodules (0.5-3.0 cm in diameter), bullae and erythematous plaques distributed all over the body including the trunk and the ventral aspect of extremities. Tender nodules were felt on the extensor surface of the hands and shin [ Figure 1a -d]. She also had mild splenomegaly. A biopsy from the largest Three weeks following the appearance of the initial skin lesions, the symptoms gradually worsened and the patient developed severe pain in the bones coupled with high fever, anorexia, night sweats and productive cough with purpura and ecchymosis in the skin. Physical examination revealed gum hypertrophy with mild splenomegaly. Laboratory investigations revealed moderate anemia, leukocytosis and severe thrombocytopenia with an erythrocyte sedimentation rate of 76 mm/h and raised lactate dehydrogenase levels of 564 IU.
Further investigations revealed obvious signs of relapsed acute monocytic leukemia in both the peripheral blood smear (5% of blasts) and the bone marrow aspirate (32% blasts) [ Figure 2d ]. The blast cells were large with abundant moderately basophilic cytoplasm. Although a partial remission was obtained after a course of aggressive chemotherapy with FLAG-IDA (fludarabine 30 mg/m², Ara-C 2 g/m² for 5 days, idarubicin 10 mg/m² for 3 days and granulocyte-colony stimulating factor from day 6 until neutrophil recovery), the patient could not achieve a complete remission. Eventually, she died 35 days after the initial presentation with skin lesions. Death was attributed to complications including severe febrile neutropenia and septicemia.
Leukemia cutis is an extramedullary skin infiltration which usually occurs in leukemias, especially in acute monocytic and myelomonocytic leukemias. It may, sometimes, occur before the appearance of peripheral and/or bone marrow leukemia (called aleukemic leukemia cutis) or it may occur concomitantly with systemic leukemia or after a complete remission. The duration may range from weeks to months or even more. [4] Cases of leukemia cutis are often associated with a bad prognosis. [1, 5, 6] Therefore, once a patient is diagnosed to have leukemia cutis, urgent treatment with aggressive chemotherapy is required. Our patient was treated with FLAG-IDA protocol and had entered a period of pancytopenia and febrile neutropenia but eventually died 35 days after the diagnosis of leukemia cutis.
Isolated extramedullary recurrence of acute non-lymphoblastic leukemias always heralds bone marrow relapse and should be treated with re-induction chemotherapy. [7] The increased risk of extramedullary relapse is presumably related to the higher incidence of extramedullary disease as in FAB (French-AmericanBritish classification) M4 and M5 subclasses. [8] However, very rarely, leukemia cutis precedes peripheral or bone marrow leukemia as noted in our case.
To sum up, we describe a case of aleukemic leukemia cutis which preceded the relapse of acute monocytic leukemia occurring after a complete remission, with aggressive symptoms and a very short survival time. Due to its aggressive clinical presentation, we strongly recommend that aleukemic leukemia cutis be carefully sought when patients with a history of leukemia, when develop cutaneous nodules.
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